Nuclear Medicines Radioisotopes Market Statistics, Size, Share Analysis 2020-2026 | Global Key Players: Cardinal Health, Positron Corporation, General Electric Company, Aenorasis Siemens Healthcare Private Limited, Bayer, Hologic

Nuclear Medicines Radioisotopes Market Size is poised to grow at notable CAGR and reach remarkable market value during 2020 to 2026. COVID-19 impact on Global Nuclear Medicines Radioisotopes Market is analyzed in this report. Report segments Nuclear Medicines Radioisotopes Market Size, Share and Global Trend By Product Type (Diagnostics, Therapeutic), By Application (Oncology, Gastroenterology, Neurology, Orthopedics, Others), By End-user (Hospitals, Diagnostic centers, Specialty clinics, Education and research institutes, Others) and Geography Forecast till 2026.

Get Free Sample Nuclear Medicines Radioisotopes Market Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nuclear-medicines-radioisotopes-market-101055

Leading Key players in the global Nuclear Medicines Radioisotopes include: Cardinal Health, Positron Corporation, General Electric Company, Aenorasis Siemens Healthcare Private Limited, Bayer, Hologic.

Nuclear medicines are used for imaging purposes and the procedures are carried out using radiotracers. These radiotracers are essentially molecules linked with a very small amount of radioactive material. They are then injected, swallowed or inhaled. The radiotracer travels in the area under inspection through the bloodstream and emanates signals or energy in the form of gamma rays, which is detected on the PET scan camera. A radioisotope is an artificially produced isotope that has an unnatural combination of protons and neutrons.

Widespread awareness of radioisotopes in medicines, particularly for diagnosis and therapy, is expected to provide a forward thrust to the global nuclear medicines isotopes market in the approaching decade. For instance, the World Nuclear Association notes that over 10,000 hospitals worldwide use medicines containing radioisotopes. Moreover, about 90% of the procedures are done for diagnostic purposes. Technetium-99 is the most common radioisotope used in diagnosis, featuring in almost 80% of the total procedures performed. Another important advantage of the technetium radioisotope is its half-life of six hours. This property makes it ideal for diagnosis as its long enough to investigate the problem, but short enough to do any harm to the patient.

According to the World Nuclear Association, diagnostic methods employing radioisotopes has become commonplace the world over. The organization also reveals that the demand for radioisotopes is increasing by 5% annually, with the number of nuclear medicines procedures exceeding 40 mn. This bodes well for the global nuclear medicines radioisotopes market size as the demand for PET scans and nuclear medicinal procedures make the market more lucrative.

Market Segmentation:

The global Nuclear Medicine Radioisotope Market Trends has been segmented based on Product Type, Application Type, End-user, and Region.

By Product Type, the Market for Nuclear Medicine Radioisotope has been segmented into Diagnostics, Therapeutic.

By mode of Application, the Market for Nuclear Medicine Radioisotope has been segmented into Oncology, Gastroenterology, Neurology, Orthopedics, Others.

By mode of End-user, the market has been segmented into Hospitals, Diagnostic centers, Specialty clinics, Education and research institutes, Others.

By mode of Region, the Nuclear Medicine Radioisotope Industry has been segmented into North America, Asia-Pacific, Europe, Middle East-Africa, South America and Rest of the World.

Intended Audience:

Nuclear Medicines Radioisotopes Key Players

Nuclear Medicines Radioisotopes Suppliers

Research and Development (RandD) Companies

Distributer and Supplier companies

End Users

Consultants and Investment bankers

Government as well as Independent Regulatory Authorities

Global Nuclear Medicines Radioisotopes Market: Geographical Analysis:

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Nuclear Medicines Radioisotopes Market: Competitive Landscape:

The report also focuses on global major leading industry players of Global Nuclear Medicines Radioisotopes Market providing information such as company profiles, product picture and specification, capacity, cost, production, price, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. Nuclear Medicines Radioisotopes Market Forecast 2025 report study provides key statistics on the market status of the Nuclear Medicines Radioisotopes Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Table of content

Table of Contents

1 Market Overview

1.1 Nuclear Medicines Radioisotopes Market Introduction

1.2 Market Analysis by Type

1.3 Market Analysis by Applications

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.4 South America, Middle East and Africa

1.5 Market Dynamics

Browse more at: https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicines-radioisotopes-market-101055

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights Pvt. Ltd.

Supreme Headquarters,

Pune Banglore Highway, Baner, Pune,

Maharashtra 411045, India

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Pune Banglore Highway Pashan Exit, Baner, Pune, Maharashtra 411045, India

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

This release was published on openPR.